Skip to main content

‘’2016 was a major year for Pharming. During the year we achieved a number of positive milestones that culminated in December in the game-changing re-acquisition of commercialization rights for RUCONEST® in North America"

- Dr Sijmen de Vries, Pharming’s CEO
Cookies: This website uses cookies Check the cookies page for more information Accept Decline